Summary & Overview
CPT 92609: Therapeutic Services for Speech Generating Device Users
CPT code 92609 covers therapeutic services for patients who use speech generating devices, a critical intervention for individuals with communication disorders. This code is nationally recognized for its role in supporting patients with conditions such as aphasia, phonological disorders, and expressive or mixed receptive-expressive language disorders. The service includes both direct patient therapy and caregiver training, ensuring comprehensive support for device utilization.
Major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare provide coverage for these services, reflecting broad national access. Readers will gain insight into payer coverage, clinical indications, and the typical outpatient settings where these services are delivered. The publication also addresses relevant modifiers, associated provider taxonomies, and related CPT and ICD-10 codes, offering a complete overview of billing and clinical context for speech-language pathology professionals. Policy updates and benchmarks are included to inform stakeholders about current trends and requirements for therapeutic speech device services.
CPT Code Overview
CPT code 92609 is used for therapeutic services that help patients maximize the use of their speech generating devices. The provider works directly with the patient to improve communication abilities and also trains caregivers to support device use. This service falls under Evaluative and Therapeutic Otorhinolaryngologic Services and is typically performed in a speech-language pathology outpatient setting, such as an office (Place of Service 11).
Clinical & Coding Specifications
Clinical Context
A patient with a diagnosed speech or language disorder, such as aphasia or expressive language disorder, is referred to a speech-language pathologist for therapeutic intervention. The patient has been prescribed a speech generating device to assist with communication. During an outpatient visit, the speech-language pathologist provides targeted therapy to help the patient maximize the use of their device. The session also includes training for the patient's caregiver to ensure effective support at home. This service is typically performed in a speech-language pathology clinic or office setting.
Coding Specifications
-
Modifiers:
- Modifier
GN: Indicates services delivered under an outpatient speech-language pathology plan of care. - Modifier
52: Used when services are reduced from the usual level, such as a shortened session or partial service.
- Modifier
-
Provider Taxonomies:
Taxonomy Code Specialty Name 235Z00000XSpeech-Language Pathologist 261QH0700XHearing and Speech Clinic/Center 225X00000XRehabilitation Practitioner
Related Diagnoses
-
F80.0- Phonological disorder- Relevant for patients with difficulty in speech sound production, which may necessitate a speech generating device.
-
F80.1- Expressive language disorder- Applies to patients who struggle to express themselves verbally, benefiting from device-assisted communication.
-
F80.2- Mixed receptive-expressive language disorder- Pertains to patients with both understanding and expressive language difficulties, often requiring comprehensive therapy and device support.
-
R47.01- Aphasia- Indicates loss of ability to understand or express speech, commonly seen in patients post-stroke or brain injury, who may need a speech generating device.
-
R48.8- Other symbolic dysfunctions- Covers other communication impairments affecting symbolic language, relevant for device-based speech therapy.
Related CPT Codes
-
92607- Selection and prescription of speech‑generating device- This code is used when the provider evaluates the patient and selects the most appropriate speech-generating device. It is commonly performed prior to the therapeutic services described by
92609. Both codes may be used together in a clinical workflow, with92607for device selection and92609for subsequent therapy and training.
- This code is used when the provider evaluates the patient and selects the most appropriate speech-generating device. It is commonly performed prior to the therapeutic services described by
National Reimbursement Benchmarks
For CPT code 92609, national mean rates show that Medicare reimburses at $106.35, while the average commercial benchmark (BUCA) is higher at $137.97. UnitedHealth Group and Cigna have the highest mean rates among major payers, at $172.10 and $167.74 respectively, with Aetna and Medicare at the lower end.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare has the tightest range ($9.00), indicating consistent reimbursement, while UnitedHealth Group ($105.00) and Cigna ($96.00) exhibit the widest spreads, reflecting greater variability in commercial rates. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.